Pugasin Eye Drops (Ofloxacin)

Adult eye dose

Instill (apply) 1 drop 3 times daily. Adjust appropriately according to symptoms.

This drug should not be used in patients with hypersensitivity to fluoroquinolone antibiotics. Rarely, serious allergic reactions such as shock may occur when using this drug, so if symptoms such as nausea, cold extremities, or difficulty breathing appear, the use should be immediately discontinued and appropriate treatment sought. Additionally, if symptoms of hypersensitivity such as cardiovascular collapse, loss of consciousness, angioedema, airway obstruction, rash, urticaria, itching, eyelid swelling, skin redness, or conjunctival injection occur, use should be discontinued. Transient burning or irritation, discomfort may occur in the eye, and sometimes pain, redness, itching, conjunctivitis, keratitis, periorbital edema, foreign body sensation, photophobia, blurriness, tearing, dryness, ocular pain may also occur; if these symptoms appear, use should be discontinued. Rarely, dizziness or corneal disturbances, and in severe cases, serious skin reactions such as Stevens-Johnson syndrome may occur, so caution is advised. Auditory impairment or irritation symptoms may also occur. This drug should be used only for the minimum necessary duration after performing a sensitivity test to prevent the emergence of resistant bacteria. Long-term use should be avoided as it may lead to excessive proliferation of fungi or non-susceptible bacteria, and in cases of secondary infections, treatment should be switched to other therapies. For the treatment of trachoma, an 8-week duration of treatment is standard, and after that, the decision on whether to continue treatment should be made carefully. When treatment is ongoing, wearing soft contact lenses should be avoided. Women who are pregnant or may become pregnant should carefully consider the risks and benefits of using this drug, and nursing mothers should either discontinue breastfeeding or stop using the medication during treatment. It is advisable not to use this drug in infants under 1 year of age as its safety and efficacy have not been established. This drug is to be used only for ophthalmic purposes, and care should be taken to avoid direct contact between the tip of the container and the eye. To prevent contamination, it is recommended to avoid sharing. When storing, keep it out of reach of children, away from direct sunlight, and in a cool and dry place. Additionally, to maintain quality, do not transfer it to other containers.

• Area
• limb coldness
• dyspnea
• cardiovascular collapse
• loss of consciousness
• vascular edema
• airway obstruction
• rash
• urticaria
• itching

This drug must be stored in a sealed container to prevent air and moisture ingress, and it is important to store it at room temperature away from direct sunlight. This will help maintain the effectiveness of the medication and prevent degradation.

Appearance

A clear, pale yellow to amber transparent liquid in a clear plastic container.

Package unit

5 mL/bottle x 1